Hot sectors in a tepid recovery
The energy, finance, technology and healthcare industries are expected to be the hottest areas for dealmaking in 2010. Full Article | Full Coverage
TABLE-Trubion Pharmaceuticals Q1 net loss widens
May 14 (Reuters) -
TRUBION PHARMACEUTICALS INC. (TRBN.O)
(in $) Latest Yr-ago qtr
Loss/shr (diluted) 0.29 1.80
Net loss (million) 5.0 2.4
Collaboration revenue (mln) 4.8 5.8
Reuters Estimates: EPS -$0.35 (three analysts), revenue $5.5
million (two analysts)
--The biopharmaceutical company said the number of shares used in computing diluted net loss per share for the latest first quarter was about 17.6 million compared with 1.3 million last year. (Reporting by Manish Gupta in Bangalore)











